Agmatine transport into spinal nerve terminals is modulated by polyamine analogs

Journal of Neurochemistry

Volumn 100, Issue 1, 2007, Pages 132-141

  Goracke Postle, Cory J ^a   Overland, Aaron C ^a   Stone, Laura S ^a   Fairbanks, Carolyn A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Neuromodulation; Plasticity; Spermine

Indexed keywords

4 AMINOBUTYRIC ACID; AGMATINE; ARGININE; CALCIUM ION; EFLORNITHINE; GLUTAMIC ACID; GLYCINE; MITOGUAZONE; NORADRENALIN; PARAQUAT; POLYAMINE; POLYAMINE DERIVATIVE; PUTRESCINE; SEROTONIN; SPERMIDINE;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL NERVE; SYNAPTOSOME; TEMPERATURE DEPENDENCE; TRANSPORT KINETICS;

AGMATINE; ANALYSIS OF VARIANCE; ANIMALS; AXONAL TRANSPORT; BINDING, COMPETITIVE; BIOGENIC POLYAMINES; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PARAQUAT; PUTRESCINE; PYRUVALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES; SYNAPTOSOMES; TEMPERATURE; TIME FACTORS; TRITURUS;

EID: 33846143548     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04193.x     Document Type: Article

References (59)

1. Aricioglu-Kartal F. and Regunathan S. (2002) Effect of chronic morphine treatment on the biosynthesis of agmatine in rat brain and other tissues. Life Sci. 71, 1695-1701.
2. Askalany A. R., Yamakura T., Petrenko A. B., Kohno T., Sakimura K. and Baba H. (2005) Effect of agmatine on heteromeric N-methyl-D- aspartate receptor channels. Neurosci. Res. 52, 387-392.
3. Babal P., Ruchko M., Olson J. W. and Gillespie M. N. (2000) Interactions between agmatine and polyamine uptake pathways in rat pulmonary artery endothelial cells. Gen. Pharmacol. 34, 255-261.
4. Berlese D. B., Sauzem P. D., Carati M. C., Guerra G. P., Stiegemeier J. A., Mello C. F. and Rubin M. A. (2005) Time-dependent modulation of inhibitory avoidance memory by spermidine in rats. Neurobiol. Learn. Mem. 83, 48-53.
5. Breukel A. I. M., Besselsen E., Lopes da Silva F. H. and Ghijsen W. E. J. M. (1998) A presynaptic N-methyl-D-aspartate autoreceptor in rat hippocampus modulating amino acide release from a cytoplasmic pool. Eur. J. Neurosci. 10, 106-114.
6. Bröer S. (2006) The SLC6 orphans are forming a family of amino acid transporters. Neurochem. Int. 48, 559-567.
7. Buzzi M. G. and Moskowitz M. A. (1991) Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 11, 165-168.
8. Byers T. L., Kameji R., Rannels D. E. and Pegg A. E. (1987) Multiple pathways for uptake of paraquat, methylglyoxal bis (guanylhydrazone), and polyamines. Am. J. Physiol. 252, C663-C669.
9. Cabella C., Gardini G., Corpillo D., Testore G., Bedino S., Solinas S. P., Cravanzola C., Vargiu C., Grillo M. A. and Colombatto S. (2001) Transport and metabolism of agmatine in rat hepatocyte cultures. Eur J. Biochem. 268, 940-947.
10. Conway E. L. (1998) Brain lesions and delayed water maze learning deficits after intracerebroventricular spermine. Brain Res. 800, 10-20.
11. DeFeudis F. V. (1975) 'Binding' of gamma-aminobutyric acid and glycine to synaptosome-enriched fractions of rat cerebral cortex and spinal cord. Exp. Neurol. 47, 189-193.
12. Demady D. R., Jianmongkol S., Vuletich J. L., Bender A. T. and Osawa Y. (2001) Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol. Pharmacol. 59, 24-29.
13. Dingledine R., Borges K., Bowie D. and Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
14. Fairbanks C. A. and Wilcox G. L. (1997) Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J. Pharmacol. Exp. Ther. 282, 1408-1417.
15. Fairbanks C. A., Schreiber K. L., Brewer K. L. et al. (2000) Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc. Natl Acad. Sci. USA 97, 19 584-19 589.
16. Feng Y., LeBlanc M. H. and Regunathan S. (2005) Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci. Lett. 390, 129-133.
17. Fleck M. W., Barrionuevo G. and Palmer A. M. (2001) Synaptosomal and vesicular accumulation of L-glutamate, L-aspartate and D-aspartate. Neurochem. Int. 39, 217-225.
18. Fried G., Franck J., Brodin E., Born W., Fischer J. A., Hiort W. and Hokfelt T. (1989) Evidence for differential storage of calcitonin gene-related peptide, substance P and serotonin in synaptosomal vesicles of rat spinal cord. Brain Res. 499, 315-324.
19. Galea E., Regunathan S., Eliopoulos V., Feinstein D. L. and Reis D. J. (1996) Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316, 247-249.
20. Gibson D. A., Harris B. R., Rogers D. T. and Littleton J. M. (2002) Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res. 952, 71-77.
21. Gilad G. M. and Gilad V. H. (1991) Polyamine uptake, binding and release in rat brain. Eur J. Pharmacol. 193, 41-46.
22. Gilad G. M. and Gilad V. H. (2000) Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci. Lett. 296, 97-100.
23. Goracke-Postle C. J., Nguyen H. O. X., Stone L. S. and Fairbanks C. A. (2006) Release of tritiated agmatine from spinal synaptosomes. Neuroreport 17, 13-17.
24. Grabie V., Scemama J. L., Robertson J. B. and Seidel E. R. (1993) Paraquat uptake in the cultured gastrointestinal epithelial cell line, IEC-6. Toxicol. Appl. Pharmacol. 122, 95-100.
25. Horn A. S. (1978) Characteristics of neuronal dopamine uptake. Adv. Biochem. Psychopharmacol. 19, 25-34.
26. Horvath G., Kekesi G., Dobos I., Szikszay M., Klimscha W. and Benedek G. (1999) Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. Eur. J. Pharmacol. 368, 197-204.
27. Igarashi K., Ito K. and Kashiwagi K. (2001) Polyamine uptake systems in Escherichia coli. Res. Microbiol. 152, 271-278.
28. 2+-ATPase. J. Cell. Physiol. 157, 493-501.
29. Kishi A., Ohno M. and Watanabe S. (1998) Spermidine, a polyamine site agonist, attenuates working memory deficits caused by blockade of hippocampal muscarinic receptors and mGluRs in rats. Brain Res. 793, 311-314.
30. Kolesnikov Y., Jain S. and Pasternak G. W. (1996) Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296, 17-22.
31. Li G., Regunathan S., Barrow C. J., Eshraghi J., Cooper R. and Reis D. J. (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263, 966-969.
32. Li Q., Yin J. X. and He R. R. (2002) Effect of agmatine on 1-type calcium current in rat ventricular myocytes. Acta Pharmacol. Sin. 23, 219-224.
33. Li X. T., Duan H. R. and He R. R. (2000) Inhibition by agmatine on spontaneous activity of rabbit atrioventricular node cells. Acta Pharmacol. Sin. 21, 931-935.
34. Marton L. J. and Pegg A. E. (1995) Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35, 55-91.
35. Masuko T., Kusama-Eguchi K., Sakata K., Kusama T., Chaki S., Okuyama S., Williams K., Kashiwagi K. and Igarashi K. (2003) Polyamine transport, accumulation, and release in brain. J. Neurochem. 84, 610-617.
36. Millan M. J. (1999) The induction of pain: an integrative review. Prog. Neurobiol. 57, 1-164.
37. Milovic V., Stein J., Piiper A., Gerhard R., Zeuzem S. and Caspary W. F. (1995) Characterization of putrescine transport across the intestinal epithelium: study using isolated brush border and basolateral membrane vesicles of the enterocyte. Eur. J. Clin. Invest. 25, 97-105.
38. Molderings G. J., Bonisch H., Gothert M. and Bruss M. (2001) Agmatine and putrescine uptake in the human glioma cell line SKMG-1. Naunyn Schmiedebergs Arch. Pharmacol. 363, 671-679.
39. Morgan A. D., Campbell U. C., Fons R. D. and Carroll M. E. (2002) Effects of agmatine on the escalation of i.v. cocaine and fentanyl self-administration in rats. Pharmacol. Biochem. Behav. 72, 873-880.
40. Nguyen H. O., Goracke-Postle C. J., Kaminski L. L., Overland A. O., Morgan A. D. and and. Fairbanks C. A. (2003) Neuropharmacokinetic and dynamic studies of agmatine. Ann. N. Y. Acad. Sci. 1009, 82-105.
41. Otake K., Ruggiero D. A., Regunathan S., Wang H., Milner T. A. and Reis D. J. (1998) Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res. 787, 1-14.
42. Poulin R., Lessard M. and Zhao C. (1995) Inorganic cation dependence of putrescine and spermidine transport in human breast cancer cells. J. Biol. Chem. 270, 1695-1704.
43. Raasch W., Regunathan S., Li G. and Reis D. J. (1995) Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 56, 2319-2330.
44. Regunathan S., Feinstein D. L., Raasch W. and Reis D. J. (1995) Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport 6, 1897-1900.
45. Reis D. J. and Regunathan S. (1998) Agmatine: a novel neurotransmitter? Adv. Pharmacol. 42, 645-649.
46. Reynolds I. J. (1990) Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 255, 1001-1007.
47. Roberts J. C., Grocholski B. M., Kitto K. F. and Fairbanks C. A. (2005) Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J. Pharmacol. Exp. Ther. 314, 1226-1233.
48. Rubin M. A., Berlese D. B., Stiegemeier J. A., Volkweis M. A., Oliveira D. M., dos Santos T. L., Fenili A. C. and Mello C. F. (2004) Intra-amygdala administration of polyamines modulates fear conditioning in rats. J. Neurosci. 24, 2328-2334.
49. Sastre M., Regunathan S. and Reis D. J. (1997) Uptake of agmatine into rat brain synaptosomes: Possible role of cation channels. J Neurochem. 69, 2421-2426.
50. Satriano J., Isome M., Casero R. A. Jr, Thomson S. C. and Blant R. C. (2001) Polyamine transport system mediates agmatine transport in mammalian cells. Am. J. Physiol. Cell Physiol. 281, C329-C334.
51. 3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain. Eur J. Pharmacol. 225, 167-169.
52. Seiler N., Delcros J. G. and Moulinoux J. P. (1996) Polyamine transport in mammalian cells. An update. Int. J. Biochem. Cell Biol. 28, 843-861.
53. Uemura T., Tachihara K., Tomitori H., Kashiwagi K. and Igarashi K. (2005) Characteristics of the polyamine transporter TPO1 and regulation of its activity and cellular localization by phosphorylation. J. Biol. Chem. 280, 9646-9652.
54. del Valle A. E., Paz J. C., Sanchez-Jimenez F. and Medina M. A. (2001) Agmatine uptake by cultured hamster kidney cells. Biochem. Biophys. Res. Commun. 280, 307-311.
55. Weng X. C., Gai X. D., Zheng J. Q. and Li J. (2003) Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol. Sin. 24, 746-750.
56. Williams K. (1997) Interactions of polyamines with ion channels. Biochem. J. 325, 289-297.
57. 3H-GABA by hyperforin, a major constituent of St John's Wart: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23, 188-197.
58. Yang X. C. and Reis D. L. (1999) Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 288, 544-549.
59. Yu C. G., Marcillo A. E., Fairbanks C. A., Wilcox G. L. and Yezierski R. P. (2000) Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 11, 959-965.